The global contract research organization (CRO)market size was valued at USD 60.85 billion in 2023 and is anticipated to reach around USD 118.81 billion by 2033, growing at a CAGR of 6.92% from 2024 to 2033. As the pharmaceutical and biotechnology industries continue to advance, the demand for the contract research organization (CRO) market is likely to grow further.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The U.S. contract research organization (CRO) market size was estimated at USD 18.74 billion in 2023 and is predicted to be worth around USD 37.27 billion by 2033 with a CAGR of 7.11% from 2024 to 2033.
North American dominated the Contract Research Organization (CRO) Market in 2023. The growth of the market in North America is primarily driven by the expanding pharmaceutical and biotechnology sectors in the region. The United States holds the largest share of the market, followed by Canada. Factors contributing to the growth of the CRO market in the U.S. include its robust pharmaceutical and biotechnology industries, a high concentration of clinical research facilities, and advanced infrastructure and technology. Canada ranks as the second-largest CRO market in North America.
Asia Pacific is expected to show the fastest growth in the Contract Research Organization (CRO) Market during the forecast period. Asian countries, particularly China and India, have experienced a significant increase in clinical trial activities. Furthermore, Diverse patient populations and lower operational costs have attracted pharmaceutical and biotech companies to conduct trials in the region, hence boosting the demand for CRO services. This growth is driven by the expanding presence of pharmaceutical and biotechnology firms in Asia, along with the rising number of clinical trials being conducted in the region. The large population in Asia is also a key factor contributing to the CRO market's growth.
The Asia Pacific contract research organization (CRO) market size was calculated at USD 12.17 billion in 2023 and is projected to expand around USD 24.26 billion by 2033, poised to grow at a CAGR of 7.18% from 2024 to 2033.
| Forecast Year | Market Size in USD |
| 2023 | $ 12.17 Billion |
| 2024 | $ 13.01 Billion |
| 2025 | $ 13.91 Billion |
| 2026 | $ 14.87 Billion |
| 2027 | $ 15.90 Billion |
| 2028 | $ 17.00 Billion |
| 2029 | $ 18.18 Billion |
| 2030 | $ 19.44 Billion |
| 2031 | $ 20.78 Billion |
| 2032 | $ 22.22 Billion |
| 2033 | $ 24.36 Billion |
A contract research organization (CRO) provides clinical trial services to the pharmaceutical, biotechnology, and medical device industries. Typical services offered by CROs in the medical device sector include regulatory affairs, clinical trial planning, site selection and initiation, trial logistics, biostatistics, recruitment support, clinical monitoring, data management, medical writing, and project management. Sponsors seeking to conduct clinical trials often engage CROs to avoid the need for full-time staff and to leverage the CRO's expertise on an as-needed basis.
The CRO is responsible for the safe and effective planning, coordination, execution, and management of the clinical trial's lifecycle. Acting as the primary liaison between the sponsor and other stakeholders, the CRO interacts with suppliers, medical professionals, research coordinators, regulatory staff, ethical and compliance committees, and vendors throughout the trial. Various types of CROs cater to different specific needs within the industry.
| Report Coverage | Details |
| Contract Research Organization (CRO) Market Size in 2023 | USD 60.85 Billion |
| Contract Research Organization (CRO) Market Size in 2024 | USD 65.06 Billion |
| Contract Research Organization (CRO) Market Size by 2033 | USD 118.81 Billion |
| Contract Research Organization (CRO) Market Growth Rate | CAGR of 6.92% from 2024 to 2033 |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Type, Service, End-user, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Need for cost-effective drugs
The contract research organization (CRO) market is experiencing exponential growth during the forecast period due to several key factors, including the availability of research funds, government support for R&D, a well-developed healthcare sector, and rising healthcare expenditures. The increasing global patient population also contributes significantly to market expansion. Key drivers of growth in the CRO industry include the need for cost-effective drug development processes, the rising prevalence of chronic diseases, and the surge in outsourcing to expedite R&D activities. Additionally, the growing adoption of virtual trials, remote monitoring, and telemedicine is further boosting the demand for contract research organization services.
Restraint: Issues surrounding intellectual property rights
When a drug development company or pharmaceutical firm collaborates with a contract research organization, the CRO gains access to critical information related to drug research and patented products. This access increases the risk of data leakage or intellectual property infringement. Although legal contracts are in place to prevent such incidents, sharing confidential information with a third party inherently involves certain risks. Therefore, pharmaceutical companies must ensure the safety of their intellectual property to prevent data loss when utilizing the Contract Research Organization (CRO) Market services.
Opportunity: Tech-enabled patient recruitment and management
Patient recruitment and management pose significant challenges for clinical research organizations, sites, and sponsors. Traditionally, patient recruitment relied on manual methods such as fliers, newspaper ads, and physician referrals. However, with the advent of new technology, CROs increasingly use digital channels to reach a larger pool of potential participants. One major technological advancement is electronic data capture (EDC), which collects clinical trial data electronically instead of using paper forms. EDC solutions enhance data accuracy and completeness while streamlining the data collection process. With EDC, CROs can manage data from multiple sites, gather patient data remotely, and fix better data integrity throughout the trial. Moreover, the Contract Research Organization (CRO) Market leverages other technologies like social media and mobile apps to boost patient engagement and recruitment.
The clinical segment held a significant share of the Contract Research Organization (CRO) Market in 2023. A CRO is a specialized entity that provides essential support to pharmaceutical, biotechnology, and medical device companies in clinical research and development processes. The demand for these CROs is increasing as they focus on ensuring compliance with regulatory standards. These organizations offer a range of services, including patient recruitment, data management, protocol development, regulatory submissions, and site monitoring. As regulatory requirements become more stringent, the role of CROs in maintaining high-quality standards in clinical research is becoming increasingly vital.
The early phase development services segment is expected to grow at a rapid pace in the Contract Research Organization (CRO) market over the forecast period. PPD's early development services can conduct absorption, distribution, metabolism, and excretion (ADME) studies to understand how a drug is processed in the human body, assessing its safety and effectiveness. This capability is due to the growing investment in developing life-saving drugs.
The oncology segment dominated the Contract Research Organization (CRO) Market in 2023. The oncology segment is driven by factors such as the growing elderly population, rising cancer incidence, early cancer diagnosis and screening, and increased R&D for cancer treatments. Additionally, promising late-stage pipeline drugs and high potential in emerging markets contribute to this growth.
The CNS disorder segment is expected to show significant growth in the Contract Research Organization (CRO) Market during the forecast period. The rising prevalence of CNS disorders, including Parkinson's disease, Alzheimer's disease, multiple sclerosis, depression, epilepsy, and schizophrenia, is expected to drive the segment's growth. This increasing prevalence is boosting the demand for effective treatments for CNS disorders, thereby fueling the segment's expansion.
The pharmaceutical & biotech companies segment dominated the Contract Research Organization (CRO) Market in 2023. The growth of this sector is driven by the rising prevalence of chronic illnesses, the expanding elderly population, and the increasing adoption of new therapies. These factors have a positive impact on the market growth of Contract Research Organizations (CROs).
The CROs for the medical device segment is projected to experience the fastest growth in the Contract Research Organization (CRO) Market over the studied period. Collaborations among medical device manufacturers, healthcare providers, research institutions, and technology firms promote innovation and the creation of new devices. These partnerships allow companies to utilize their expertise, resources, and market influence, contributing to the expansion of the segment.
Segments Covered in the Report
By Type
By Service
By End-user
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
